Quantum Biopharma (QNTM) Competitors $5.24 -0.05 (-0.95%) (As of 11/14/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsTrends QNTM vs. AKTX, RNXT, GLYC, CMMB, TPST, LSB, AEON, BOLT, LSTA, and GDTCShould you be buying Quantum Biopharma stock or one of its competitors? The main competitors of Quantum Biopharma include Akari Therapeutics (AKTX), RenovoRx (RNXT), GlycoMimetics (GLYC), Chemomab Therapeutics (CMMB), Tempest Therapeutics (TPST), Lakeshore Biopharma (LSB), AEON Biopharma (AEON), Bolt Biotherapeutics (BOLT), Lisata Therapeutics (LSTA), and CytoMed Therapeutics (GDTC). These companies are all part of the "pharmaceutical preparations" industry. Quantum Biopharma vs. Akari Therapeutics RenovoRx GlycoMimetics Chemomab Therapeutics Tempest Therapeutics Lakeshore Biopharma AEON Biopharma Bolt Biotherapeutics Lisata Therapeutics CytoMed Therapeutics Quantum Biopharma (NASDAQ:QNTM) and Akari Therapeutics (NASDAQ:AKTX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, community ranking, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends. Which has preferable valuation and earnings, QNTM or AKTX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuantum BiopharmaN/AN/A-$17.90M-$15.41-0.34Akari TherapeuticsN/AN/A-$10.01MN/AN/A Does the media favor QNTM or AKTX? In the previous week, Akari Therapeutics had 3 more articles in the media than Quantum Biopharma. MarketBeat recorded 5 mentions for Akari Therapeutics and 2 mentions for Quantum Biopharma. Akari Therapeutics' average media sentiment score of 0.22 beat Quantum Biopharma's score of -0.56 indicating that Akari Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Quantum Biopharma Negative Akari Therapeutics Neutral Do institutionals and insiders hold more shares of QNTM or AKTX? 1.2% of Quantum Biopharma shares are held by institutional investors. Comparatively, 5.1% of Akari Therapeutics shares are held by institutional investors. 8.5% of Quantum Biopharma shares are held by company insiders. Comparatively, 38.9% of Akari Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in QNTM or AKTX? Akari Therapeutics received 262 more outperform votes than Quantum Biopharma when rated by MarketBeat users. CompanyUnderperformOutperformQuantum BiopharmaN/AN/AAkari TherapeuticsOutperform Votes26252.19% Underperform Votes24047.81% Which has more volatility & risk, QNTM or AKTX? Quantum Biopharma has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Comparatively, Akari Therapeutics has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Is QNTM or AKTX more profitable? Akari Therapeutics' return on equity of 0.00% beat Quantum Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Quantum BiopharmaN/A -91.14% -65.53% Akari Therapeutics N/A N/A N/A SummaryAkari Therapeutics beats Quantum Biopharma on 9 of the 9 factors compared between the two stocks. Ad Porter & CompanyThe next assassination attempt won’t be on TrumpPresident Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you watched the President’s 25-minute victory speech, you probably noticed he spent nearly four minutes speaking about one very controversial person.I share with you in this special investigative documentary. Get Quantum Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for QNTM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QNTM vs. The Competition Export to ExcelMetricQuantum BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.81M$7.04B$5.38B$8.88BDividend YieldN/A8.03%4.99%4.03%P/E Ratio-0.3411.49127.4917.46Price / SalesN/A348.331,259.5192.75Price / CashN/A49.2239.4136.42Price / Book0.259.096.295.86Net Income-$17.90M$154.47M$119.70M$225.15M7 Day Performance-3.68%-2.22%-1.07%-0.90%1 Month Performance8.71%7.49%3.64%3.70%1 Year PerformanceN/A37.73%36.57%26.40% Quantum Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QNTMQuantum BiopharmaN/A$5.24-0.9%N/AN/A$6.81MN/A-0.34N/AAKTXAkari TherapeuticsN/A$2.23-0.4%N/A-34.1%$27.08MN/A0.009Short Interest ↑News CoverageGap UpRNXTRenovoRx2.5626 of 5 stars$1.09flat$6.13+461.9%+3.8%$26.15MN/A-1.826Short Interest ↓News CoverageGap UpGLYCGlycoMimetics4.0595 of 5 stars$0.40flat$10.00+2,403.8%-69.8%$25.76M$10,000.00-0.6950Upcoming EarningsAnalyst ForecastShort Interest ↑CMMBChemomab Therapeutics2.7304 of 5 stars$1.74flat$5.67+225.7%+216.4%$24.99MN/A-1.5320Short Interest ↑News CoverageGap UpTPSTTempest Therapeutics3.0804 of 5 stars$0.97flat$20.00+1,961.6%-72.0%$24.45MN/A-0.6320Analyst ForecastShort Interest ↓News CoverageLSBLakeshore Biopharma0.5669 of 5 stars$2.59-10.7%N/AN/A$24.11M$80.82M0.00773Short Interest ↑Gap UpHigh Trading VolumeAEONAEON Biopharma2.1924 of 5 stars$0.61-11.6%$5.00+719.5%-82.8%$23.87MN/A0.005News CoverageBOLTBolt Biotherapeutics3.683 of 5 stars$0.62+1.6%$3.50+462.3%-37.0%$23.82M$11.17M-0.36100Earnings ReportAnalyst ForecastShort Interest ↓LSTALisata Therapeutics3.3297 of 5 stars$2.81+0.7%$15.00+433.8%+30.4%$23.38MN/A-1.1230Short Interest ↓Gap DownGDTCCytoMed Therapeutics2.3798 of 5 stars$2.12-4.5%$5.00+135.8%-44.9%$23.19MN/A0.00N/AShort Interest ↓Positive NewsGap Up Related Companies and Tools Related Companies Akari Therapeutics Alternatives RenovoRx Alternatives GlycoMimetics Alternatives Chemomab Therapeutics Alternatives Tempest Therapeutics Alternatives Lakeshore Biopharma Alternatives AEON Biopharma Alternatives Bolt Biotherapeutics Alternatives Lisata Therapeutics Alternatives CytoMed Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:QNTM) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quantum Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quantum Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free QNTM Stock Alerts